158 related articles for article (PubMed ID: 34027244)
1. Gaining acceptance in next generation PBK modelling approaches for regulatory assessments - An OECD international effort.
Paini A; Tan YM; Sachana M; Worth A
Comput Toxicol; 2021 May; 18():100163. PubMed ID: 34027244
[TBL] [Abstract][Full Text] [Related]
2. Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.
Paini A; Leonard JA; Joossens E; Bessems JGM; Desalegn A; Dorne JL; Gosling JP; Heringa MB; Klaric M; Kliment T; Kramer NI; Loizou G; Louisse J; Lumen A; Madden JC; Patterson EA; Proença S; Punt A; Setzer RW; Suciu N; Troutman J; Yoon M; Worth A; Tan YM
Comput Toxicol; 2019 Feb; 9():61-72. PubMed ID: 31008414
[TBL] [Abstract][Full Text] [Related]
3. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.
Najjar A; Punt A; Wambaugh J; Paini A; Ellison C; Fragki S; Bianchi E; Zhang F; Westerhout J; Mueller D; Li H; Shi Q; Gant TW; Botham P; Bars R; Piersma A; van Ravenzwaay B; Kramer NI
Arch Toxicol; 2022 Dec; 96(12):3407-3419. PubMed ID: 36063173
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
Paini A; Worth A; Kulkarni S; Ebbrell D; Madden J
Comput Toxicol; 2021 May; 18():100159. PubMed ID: 34027243
[TBL] [Abstract][Full Text] [Related]
5. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment.
Reale E; Zare Jeddi M; Paini A; Connolly A; Duca R; Cubadda F; Benfenati E; Bessems J; S Galea K; Dirven H; Santonen T; M Koch H; Jones K; Sams C; Viegas S; Kyriaki M; Campisi L; David A; Antignac JP; B Hopf N
Environ Int; 2024 Feb; 184():108474. PubMed ID: 38350256
[TBL] [Abstract][Full Text] [Related]
6. Use of Physiologically-Based Kinetics Modelling to Reliably Predict Internal Concentrations of the UV Filter, Homosalate, After Repeated Oral and Topical Application.
Najjar A; Schepky A; Krueger CT; Dent M; Cable S; Li H; Grégoire S; Roussel L; Noel-Voisin A; Hewitt NJ; Cardamone E
Front Pharmacol; 2021; 12():802514. PubMed ID: 35058784
[TBL] [Abstract][Full Text] [Related]
7. A generic avian physiologically-based kinetic (PBK) model and its application in three bird species.
Baier V; Paini A; Schaller S; Scanes CG; Bone AJ; Ebeling M; Preuss TG; Witt J; Heckmann D
Environ Int; 2022 Nov; 169():107547. PubMed ID: 36179644
[TBL] [Abstract][Full Text] [Related]
8. Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans.
Geci R; Gadaleta D; de Lomana MG; Ortega-Vallbona R; Colombo E; Serrano-Candelas E; Paini A; Kuepfer L; Schaller S
Arch Toxicol; 2024 May; ():. PubMed ID: 38722347
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment.
Pletz J; Blakeman S; Paini A; Parissis N; Worth A; Andersson AM; Frederiksen H; Sakhi AK; Thomsen C; Bopp SK
Environ Int; 2020 Oct; 143():105978. PubMed ID: 32763630
[TBL] [Abstract][Full Text] [Related]
10. PBK modelling of topical application and characterisation of the uncertainty of C
Li H; Reynolds J; Sorrell I; Sheffield D; Pendlington R; Cubberley R; Nicol B
Toxicol Appl Pharmacol; 2022 May; 442():115992. PubMed ID: 35346730
[TBL] [Abstract][Full Text] [Related]
11. Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications.
Paini A; Leonard JA; Kliment T; Tan YM; Worth A
Regul Toxicol Pharmacol; 2017 Nov; 90():104-115. PubMed ID: 28866268
[TBL] [Abstract][Full Text] [Related]
12. ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.
Li H; Bunglawala F; Hewitt NJ; Pendlington R; Cubberley R; Nicol B; Spriggs S; Baltazar M; Cable S; Dent M
Toxicol Sci; 2023 Oct; 196(1):1-15. PubMed ID: 37584694
[TBL] [Abstract][Full Text] [Related]
13. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
[TBL] [Abstract][Full Text] [Related]
14. Nano- and microplastic PBK modeling in the context of human exposure and risk assessment.
Wardani I; Hazimah Mohamed Nor N; Wright SL; Kooter IM; Koelmans AA
Environ Int; 2024 Apr; 186():108504. PubMed ID: 38537584
[TBL] [Abstract][Full Text] [Related]
15. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
[TBL] [Abstract][Full Text] [Related]
16. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review of Published Physiologically-based Kinetic Models and an Assessment of their Chemical Space Coverage.
Thompson CV; Firman JW; Goldsmith MR; Grulke CM; Tan YM; Paini A; Penson PE; Sayre RR; Webb S; Madden JC
Altern Lab Anim; 2021 Sep; 49(5):197-208. PubMed ID: 34836462
[TBL] [Abstract][Full Text] [Related]
18. Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data.
Punt A; Louisse J; Beekmann K; Pinckaers N; Fabian E; Van Ravenzwaay B; Carmichael PL; Sorrell I; Moxon TE
ALTEX; 2022; 39(2):221–234. PubMed ID: 35064272
[TBL] [Abstract][Full Text] [Related]
19. Next generation risk assessment for occupational chemical safety - A real world example with sodium-2-hydroxyethane sulfonate.
Wood A; Breffa C; Chaine C; Cubberley R; Dent M; Eichhorn J; Fayyaz S; Grimm FA; Houghton J; Kiwamoto R; Kukic P; Lee M; Malcomber S; Martin S; Nicol B; Reynolds J; Riley G; Scott S; Smith C; Westmoreland C; Wieland W; Williams M; Wolton K; Zellmann T; Gutsell S
Toxicology; 2024 Jun; 506():153835. PubMed ID: 38857863
[TBL] [Abstract][Full Text] [Related]
20. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
